TABLE OF CONTENTS
1 INTRODUCTION 26
1.1 OBJECTIVES OF THE STUDY 26
1.2 MARKET DEFINITION 26
1.3 OVERVIEW OF GLOBAL MULTIPLEX ASSAYS MARKET 27
1.4 CURRENCY AND PRICING 28
1.5 LIMITATION 28
1.6 MARKETS COVERED 29
2 MARKET SEGMENTATION 32
2.1 MARKETS COVERED 32
2.2 GEOGRAPHIC SCOPE 33
2.3 YEARS CONSIDERED FOR THE STUDY 34
2.4 CURRENCY AND PRICING 34
2.5 RESEARCH METHODOLOGY 35
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 38
2.7 DBMR MARKET POSITION GRID 39
2.8 DBMR MARKET CHALLENGE MATRIX 40
2.9 THE CATEGORY VS TIME GRID 41
2.10 SECONDARY SOURCES 42
2.11 ASSUMPTIONS 42
3 MARKET OVERVIEW 43
3.1 DRIVERS 45
3.1.1 USE OF MULTIPLEX ASSAYS IN COMPANION DIAGNOSTICS 45
3.1.2 ADVANTAGES OVER SINGLEPLEX AND TRADITIONAL ASSAYS 46
3.1.3 INCREASING AWARENESS ABOUT MULTIFACTORIAL NATURE OF VARIOUS DISEASES 47
3.1.4 GROWING APPLICATIONS OF MULTIPLEX ASSAYS 48
3.2 RESTRAINTS 49
3.2.1 HIGH EQUIPMENT COSTS 49
3.2.2 STRINGENT REGULATIONS AND STANDARDS 50
3.3 OPPORTUNITIES 51
3.3.1 INCREASING VALIDATION OF BIOMARKERS IN MOLECULAR AND PROTEIN DIAGNOSTICS 51
3.3.2 NEWLY AVAILABLE OR LAUNCHED PANELS FOR THE ASSAYS 52
3.4 CHALLENGES 53
3.4.1 LACK OF PROFICIENT LABOUR TO HANDLE ADVANCED PROCEDURES 53
4 EXECUTIVE SUMMARY 54
5 PREMIUM INSIGHTS 58
6 GLOBAL MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICES 61
6.1 OVERVIEW 62
6.2 REAGENTS & CONSUMABLES 63
6.3 INSTRUMENTS & ACCESSORIES 64
6.4 SOFTWARE & SERVICES 64
7 GLOBAL MULTIPLEX ASSAYS MARKET, BY TYPE 65
7.1 OVERVIEW 66
7.2 NUCLEIC ACID MULTIPLEX ASSAYS 67
7.2.1 PLANAR NUCLEIC ASSAYS 68
7.2.2 BEAD-BASED NUCLEIC ASSAYS 68
7.3 PROTEIN MULTIPLEX ASSAYS 69
7.3.1 PLANAR PROTEIN ASSAYS 69
7.3.2 BEAD-BASED PROTEIN ASSAYS 69
7.4 CELL-BASED MULTIPLEX ASSAYS 70
8 GLOBAL MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY 71
8.1 OVERVIEW 72
8.2 PROTEIN MICROARRAY 73
8.3 POLYMERASE CHAIN REACTION 74
8.4 MULTIPLEX REAL-TIME PCR 74
8.5 FLOW CYTOMETRY 75
8.6 FLUORESCENCE DETECTION 75
8.7 LUMINESCENCE 76
8.8 OTHERS 76
9 GLOBAL MULTIPLEX ASSAYS MARKET, BY APPLICATION 77
9.1 OVERVIEW 78
9.2 CLINICAL DIAGNOSTICS 79
9.2.1 CANCER 80
9.2.2 CARDIOVASCULAR DISEASES 80
9.2.3 METABOLISM & ENDOCRINOLOGY DISORDERS 80
9.2.4 INFECTIOUS DISEASES 80
9.2.5 NERVOUS SYSTEM DISORDERS 80
9.2.6 AUTOIMMUNE DISEASES 81
9.2.7 ALLERGIES 81
9.2.8 OTHERS 81
?
9.3 RESEARCH & DEVELOPMENT 81
9.3.1 DRUG DISCOVERY & DEVELOPMENT 82
9.3.2 BIOMARKER DISCOVERY & VALIDATION 82
10 GLOBAL MULTIPLEX ASSAYS MARKET, BY END USER 83
10.1 OVERVIEW 84
10.2 HOSPITALS 85
10.3 CLINICAL LABORATORIES 86
10.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIE 86
10.5 RESEARCH INSTITUTES 87
10.6 OTHERS 87
11 GLOBAL MULTIPLEX ASSAYS MARKET; BY GEOGRAPHY 88
11.1 OVERVIEW 89
11.2 NORTH AMERICA 94
11.2.1 U.S. 102
11.2.2 CANADA 107
11.2.3 MEXICO 112
11.3 EUROPE 117
11.3.1 GERMANY 125
11.3.2 U.K. 130
11.3.3 FRANCE 135
11.3.4 ITALY 140
11.3.5 SPAIN 145
11.3.6 SWITZERLAND 150
11.3.7 NETHERLANDS 155
11.3.8 BELGIUM 160
11.3.9 IRELAND 165
11.3.10 AUSTRIA 170
11.3.11 REST OF EUROPE 175
11.4 ASIA PACIFIC 176
11.4.1 CHINA 184
11.4.2 JAPAN 189
11.4.3 SOUTH KOREA 194
11.4.4 INDIA 199
11.4.5 SINGAPORE 204
11.4.6 AUSTRALIA 209
11.4.7 THAILAND 214
11.4.8 MALAYSIA 219
11.4.9 INDONESIA 224
11.4.10 PHILIPPINES 229
11.4.11 REST OF ASIA-PACIFIC 234
11.5 SOUTH AMERICA 235
11.5.1 BRAZIL 243
11.5.2 REST OF SOUTH AMERICA 248
11.6 MIDDLE EAST & AFRICA 249
11.6.1 SOUTH AFRICA 257
11.6.2 REST OF MIDDLE EAST & AFRICA 262
12 GLOBAL MULTIPLEX ASSAYS MARKET, COMPANY LANDSCAPE 263
12.1 COMPANY SHARE ANALYSIS; GLOBAL 263
12.2 COMPANY SHARE ANALYSIS; NORTH AMERICA 264
12.3 COMPANY SHARE ANALYSIS; EUROPE 265
12.4 COMPANY SHARE ANALYSIS; ASIA-PACIFIC 266
13 COMPANY PROFILE 267
13.1 THERMO FISHER SCIENTIFIC INC. 267
13.1.1 COMPANY SNAPSHOT 267
13.1.2 REVENUE ANALYSIS 267
13.1.3 COMPANY SHARE ANALYSIS 268
13.1.4 PRODUCT PORTFOLIO 268
13.1.5 RECENT DEVELOPMENTS 269
13.2 F. HOFFMANN-LA ROCHE LTD 270
13.2.1 COMPANY SNAPSHOT 270
13.2.2 REVENUE ANALYSIS 270
13.2.3 COMPANY SHARE ANALYSIS 271
13.2.4 PRODUCT PORTFOLIO 271
13.2.5 RECENT DEVELOPMENTS 272
13.3 BIO-RAD LABORATORIES, INC. 273
13.3.1 COMPANY SNAPSHOT 273
13.3.2 REVENUE ANALYSIS 273
13.3.3 COMPANY SHARE ANALYSIS 274
13.3.4 PRODUCT PORTFOLIO 274
13.3.5 RECENT DEVELOPMENTS 275
13.4 QIAGEN 276
13.4.1 COMPANY OVERVIEW 276
13.4.2 REVENUE ANALYSIS 276
13.4.3 COMPANY SHARE ANALYSIS 277
13.4.4 PRODUCT PORTFOLIO 277
13.4.5 RECENT DEVELOPMENTS 278
13.5 SIEMENS AG 279
13.5.1 COMPANY SNAPSHOT 279
13.5.2 REVENUE ANALYSIS 279
13.5.3 PRODUCT PORTFOLIO 280
13.5.4 RECENT DEVELOPMENTS 280
13.6 ABCAM PLC. 281
13.6.1 COMPANY SNAPSHOT 281
13.6.2 REVENUE ANALYSIS 281
13.6.3 PRODUCT PORTFOLIO 282
13.6.4 RECENT DEVELOPMENTS 283
13.7 AGENA BIOSCIENCE, INC. 284
13.7.1 COMPANY SNAPSHOT 284
13.7.2 GEOGRAPHICAL PRESENCE 284
13.7.3 PRODUCT PORTFOLIO 285
13.7.4 RECENT DEVELOPMENTS 285
13.8 AGILENT TECHNOLOGIES, INC. 286
13.8.1 COMPANY SNAPSHOT 286
13.8.2 REVENUE ANALYSIS 286
13.8.3 PRODUCT PORTFOLIO 287
13.8.4 RECENT DEVELOPMENTS 287
13.9 BD. 288
13.9.1 COMPANY SNAPSHOT 288
13.9.2 REVENUE ANALYSIS 288
13.9.3 PRODUCT PORTFOLIO 289
13.9.4 RECENT DEVELOPMENTS 289
13.10 BIO-TECHNE. 290
13.10.1 COMPANY SNAPSHOT 290
13.10.2 REVENUE ANALYSIS 290
13.10.3 PRODUCT PORTFOLIO 291
13.10.4 RECENT DEVELOPMENTS 291
13.11 BIOTEK INSTRUMENTS, INC. 292
13.11.1 COMPANY SNAPSHOT 292
13.11.2 GEOGRAPHICAL PRESENCE 292
13.11.3 PRODUCT PORTFOLIO 293
13.11.4 RECENT DEVELOPMENTS 293
13.12 HOLOGIC INC. 294
13.12.1 COMPANY SNAPSHOT 294
13.12.2 REVENUE ANALYSIS 294
13.12.3 PRODUCT PORTFOLIO 295
13.12.4 RECENT DEVELOPMENTS 295
13.13 ILLUMINA, INC. 296
13.13.1 COMPANY SNAPSHOT 296
13.13.2 REVENUE ANALYSIS 296
13.13.3 PRODUCT PORTFOLIO 297
13.13.4 RECENT DEVELOPMENTS 297
13.14 LUMINEX CORPORATION. 298
13.14.1 COMPANY SNAPSHOT 298
13.14.2 REVENUE ANALYSIS 298
13.14.3 PRODUCT PORTFOLIO 299
13.14.4 RECENT DEVELOPMENTS 299
13.15 MESO SCALE DIAGNOSTICS, LLC. 300
13.15.1 COMPANY SNAPSHOT 300
13.15.2 PRODUCT PORTFOLIO 300
13.15.3 RECENT DEVELOPMENTS 302
13.16 OLINK 303
13.16.1 COMPANY SNAPSHOT 303
13.16.2 GEOGRAPHICAL PRESENCE 303
13.16.3 PRODUCT PORTFOLIO 304
13.16.4 RECENT DEVELOPMENTS 304
13.17 PERKINELMER INC. 305
13.17.1 COMPANY SNAPSHOT 305
13.17.2 REVENUE ANALYSIS 305
13.17.3 PRODUCT PORTFOLIO 306
13.17.4 RECENT DEVELOPMENTS 307
13.18 QUANTERIX 308
13.18.1 COMPANY SNAPSHOT 308
13.18.2 REVENUE ANALYSIS 308
13.18.3 PRODUCT PORTFOLIO 309
13.18.4 RECENT DEVELOPMENTS 309
13.19 QUEST DIAGNOSTICS INCORPORATED. 310
13.19.1 COMPANY SNAPSHOT 310
13.19.2 REVENUE ANALYSIS 310
13.19.3 PRODUCT PORTFOLIO 311
13.19.4 RECENT DEVELOPMENTS 311
13.20 RANDOX LABORATORIES LTD. 312
13.20.1 COMPANY SNAPSHOT 312
13.20.2 GEOGRAPHICAL PRESENCE 312
13.20.3 PRODUCT PORTFOLIO 313
13.20.4 RECENT DEVELOPMENTS 313
?
13.21 SEEGENE INC. 314
13.21.1 COMPANY SNAPSHOT 314
13.21.2 REVENUE ANALYSIS 314
13.21.3 PRODUCT PORTFOLIO 315
13.21.4 RECENT DEVELOPMENTS 317
13.22 SYSMEX CORPORATION 318
13.22.1 COMPANY SNAPSHOT 318
13.22.2 REVENUE ANALYSIS 318
13.22.3 PRODUCT PORTFOLIO 319
13.22.4 RECENT DEVELOPMENTS 319
14 RELATED REPORTS 320